Erythropoietin

CHEBI:CHEBI_748960

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rxcui
1721690
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
marketing_category
DRUG FOR FURTHER PROCESSING
active_ingredient_name
ERYTHROPOIETIN
active_ingredient_strength
40000 [iU]/mL
unii
64FS3BFH5W
pharm_class
Increased Erythroid Cell Production [PE]
labeler_name
Janssen Products, LP
generic_name
ERYTHROPOIETIN
brand_name
PROCRIT
brand_name_base
PROCRIT
product_ndc
63552-137
application_number
BLA103234
manufacturer_name
Janssen Products, LP
marketing_start_date
19930816
package_marketing_start_date
30-JUN-89
spl_id
66588223-f10d-4791-8086-b4fe79811e27
package_ndc
63552-137-00
package_description
621 VIAL in 1 TRAY (63552-137-00) / 3 mL in 1 VIAL
spl_set_id
0c721ba4-ae19-417f-aae1-221ed1a0866a
upc
0359676312048